| DGOCX | VFINX | DGOCX / VFINX | |
| Total Expense Ratio | 1.75 | 0.14 | 1,250% |
| Annual Report Gross Expense Ratio | 1.76 | 0.14 | 1,257% |
| Fund Existence | 28 years | 49 years | - |
| Gain YTD | 3.962 | 1.131 | 350% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 617M | 1.48T | 0% |
| Annual Yield % from dividends | 0.03 | 1.01 | 3% |
| Returns for 1 year | -0.85 | 15.48 | -5% |
| Returns for 3 years | -2.93 | 67.54 | -4% |
| Returns for 5 years | -14.04 | 78.93 | -18% |
| Returns for 10 years | 21.38 | 268.63 | 8% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSL | 110.66 | 0.59 | +0.54% |
| Invesco DW Consumer Staples Momt ETF | |||
| GNMA | 44.56 | N/A | N/A |
| iShares GNMA Bond ETF | |||
| IBRN | 32.98 | N/A | N/A |
| iShares Neuroscience and Healthcare ETF | |||
| FELV | 36.30 | -0.01 | -0.04% |
| Fidelity Enhanced Large Cap Value ETF | |||
| TCAL | 23.64 | -0.07 | -0.30% |
| T. Rowe Price Capital Appreciation Premium Income ETF | |||